Tag Archives: celg

Video: Celgene, Alexion Earnings Top, But Stocks Fall

Big-cap biotechs Celgene (CELG) and Alexion Pharmaceuticals (ALXN) both modestly beat Q2 estimates and raised their guidance Thursday morning, but their shares were falling in the stock market today as Wall Street seemed to hope for more. Celgene’s Q2 earnings rose 18% over the year-earlier quarter to 90 cents a share, beating consensus by a penny. Sales increased 17% to $1.87 billion, about $20 million above estimates. The company added $100

Video: Celgene, Alexion Earnings Top Street, But Stocks Fall

Big-cap biotechs Celgene (CELG) and Alexion Pharmaceuticals (ALXN) both modestly beat Q2 estimates and raised their guidance Thursday morning, but their shares were falling in the stock market today as Wall Street seemed to hope for more. Celgene’s Q2 earnings rose 18% over the year-earlier quarter to 90 cents a share, beating consensus by a penny. Sales increased 17% to $1.87 billion, about $20 million above estimates. The company added $100

Celgene Drug Otezla Fails Trial, But Street Sanguine

Big-cap biotech Celgene (CELG) reported Wednesday that its drug Otezla failed a trial for an inflammatory spinal disease, but the stock rebounded from an early drop as analysts said the news wasn’t a surprise. The phase three study looked at Otezla for ankylosing spondylitis, an immunological disease that causes pain and sometimes fusion in the spinal cord. There was not a statistically significant improvement overall in patients taking Otezla vs.